Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine and Cognitive Training in Age-related Cognitive Decline
NCT03272711Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in age-related cognitive decline comparing Vortioxetine + CT with Placebo + CT (2 arms). Primary endpoint: Change in Total Fluid Cognitive Score at 4 weeks. Started Aug 2016; status: completed.
02
Drugs
vortioxetine
03
Conditions
age-related cognitive decline
Beyond the preview
Go deeper on NCT03272711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03272711.